Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria.
Proc Natl Acad Sci U S A
; 115(28): 7404-7409, 2018 07 10.
Article
in En
| MEDLINE
| ID: mdl-29954866
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Plasmodium falciparum
/
Brain
/
Malaria, Falciparum
/
Malaria, Cerebral
/
Drug Delivery Systems
/
Interleukin-33
/
NLR Family, Pyrin Domain-Containing 3 Protein
/
Antimalarials
Limits:
Animals
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: